Who Paid My Doc
Roger Klein
Molecular Genetic Pathology Beachwood, OH Medical Doctor
NPI 1750359949 CMS profile 954041
27500 Cedar Rd, Beachwood, OH 44122
General payments
$750
Research payments
$0
Ownership & investment interest
$0
Through program year 2023, Roger Klein of Beachwood, OH is reported in the CMS Open Payments database as having received $750 across 1 general payment and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
By program year
1 row| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2023 | General | $750 | 1 |
Beside peers
- Roger Klein
- Ohio median
- Middle half of Ohio
- National median
In program year 2025, general payments to Roger Klein were reported at $0. Among 40,289 Ohio profiles paid that year, the median was $159 and the middle half received between $47 and $569.
Show as a table
| Year | Roger Klein | Ohio median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $166 | $50–$652 | $163 |
| 2020 | $0 | $110 | $33–$367 | $114 |
| 2021 | $0 | $125 | $35–$432 | $132 |
| 2022 | $0 | $141 | $41–$498 | $149 |
| 2023 | $750 | $150 | $43–$522 | $160 |
| 2024 | $0 | $153 | $45–$543 | $164 |
| 2025 | $0 | $159 | $47–$569 | $169 |
Breakdown
Records
1 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Related records
Molecular Genetic Pathology in Ohio
Practitioners in the same specialty and state, ranked by reported value.
All Molecular Genetic Pathology
Everyone recorded under this specialty, nationwide.
Doctors in Ohio
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.